Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 80,087 shares at $80.97 ($6.7M) on 2020-12-30, disclosed to the SEC on 2021-01-04.
Open-market sale of $6.7M BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.03 | 2,299 | $182K | 2.7% |
| 2 | $79.03 | 2,299 | $182K | 2.7% |
| 3 | $80.12 | 3,510 | $281K | 4.2% |
| 4 | $80.12 | 3,510 | $281K | 4.2% |
| 5 | $80.97 | 8,809 | $713K | 10.7% |
| 6 | $80.97 | 8,809 |
| $713K |
| 10.7% |
| 7 | $82.00 | 5,297 | $434K | 6.5% |
| 8 | $83.12 | 2,805 | $233K | 3.5% |
| 9 | $83.12 | 2,805 | $233K | 3.5% |
| 10 | $84.06 | 8,248 | $693K | 10.4% |
| 11 | $84.06 | 8,248 | $693K | 10.4% |
| 12 | $85.16 | 3,049 | $260K | 3.9% |
| 13 | $85.16 | 3,049 | $260K | 3.9% |
| 14 | $86.27 | 6,756 | $583K | 8.7% |
| 15 | $86.27 | 6,756 | $583K | 8.7% |
| 16 | $86.96 | 769 | $67K | 1.0% |
| 17 | $86.96 | 769 | $67K | 1.0% |
| 18 | $88.22 | 1,700 | $150K | 2.3% |
| 19 | $89.66 | 600 | $54K | 0.8% |
| Total | $83.19 avg | 80,087 | $6.7M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |